Journal of Surgical Education
Volume 64, Issue 4 , Pages 212-219 , July 2007

Bloodless Surgery in a Jehovah’s Witness Patient with a 12.7-kg Uterine Leiomyosarcoma

  • Nimesh P. Nagarsheth, MD

      Affiliations

    • Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Englewood Hospital and Medical Center, Englewood, New Jersey and Mount Sinai School of Medicine, New York, New York
    • Corresponding Author InformationCorrespondence: Inquiries to Nimesh P. Nagarsheth, MD, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Medical Center, 1176 Fifth Avenue, Box 1173, New York, NY 10029-6574; fax (212) 987-6386
    • ,
  • Aryeh Shander, MD

      Affiliations

    • Department of Anesthesia, Englewood Hospital and Medical Center, Englewood, New Jersey and Mount Sinai School of Medicine, New York, New York
    • ,
  • Robert Malovany, MD

      Affiliations

    • Division of Pulmonary, Department of Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey and Mount Sinai School of Medicine, New York, New York
    • ,
  • Jausheng Tzeng, MD

      Affiliations

    • Department of Pathology, Englewood Hospital and Medical Center, Englewood, New Jersey and Mount Sinai School of Medicine, New York, New York
    • ,
  • Ibrahim Ibrahim, MD

      Affiliations

    • Department of Surgery, Englewood Hospital and Medical Center, Englewood, New Jersey and Mount Sinai School of Medicine, New York, New York

References 

  1. Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion. 2003;43:668–676
  2. Nagarsheth NP, Gupta A, Gretz HF, Javidroozi M, Adeli R, Shander A. Feasibility of bloodless surgery on a gynecologic oncology service. Int J Gynecol Cancer. 2006;16:628
  3. Sesti F, Ticconi C, Bonifacio S, Piccione E. Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery. Gynecol Obstet Invest. 2002;54:1–5
  4. Stovall TG. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer: implications for use in gynecologic surgery. J Reprod Med. 2001;46:531–538
  5. Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol. 1995;86:373–378
  6. Mirhashemi R, Averette HE, Deepika K, et al. The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol. 1999;181:1310–1315
  7. Gyamfi C, Berkowitz RL. Responses by pregnant Jehovah’s Witnesses on health care proxies. Obstet Gynecol. 2004;104:541–544
  8. PROCRIT (epoetin alfa) PRESCRIBING INFORMATION, Distributed by Ortho Biotech Products, L.P., Raritan, NJ. Rev’d January 2005. Available at: http://www.procrit.com/common/prescribing_information/PROCRIT/PDF/ProcritBooklet.pdf.
  9. Fan D, Yarnall C, Parmat JL, et al. Resection of a large atrial hemangioma using a bloodless surgical technique: a case report. Heart Surg Forum. 2007;10:E87–E89
  10. Vedantham S, Goodwin SC, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol. 1997;176:938–948
  11. Edelman M, Potter P, Mahaffey RF, Leidich R. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology. 1996;47:179–181
  12. Jabbour N, Gagandeep S, Peilin AC, et al. Recombinant human coagulation factor VIIa in Jehovah’s Witness patients undergoing liver transplantation. Am Surg. 2005;71:175–179
  13. Raivio P, Suojaranta-Ylinen R, Kuitunen AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg. 2005;80:66–71
  14. Despotis G, Avidan M, Lublin DM. Off-label use of recombinant factor VIIa concentrates after cardiac surgery. Ann Thorac Surg. 2005;80:3–5
  15. Echt G, Jepson J, Steel J, et al. Treatment of uterine sarcomas. Cancer. 1990;66(1):35–39
  16. Dinh TA, Oliva EA, Fuller AF, Lee H, Goodman AK. The treatment of uterine leiomyosarcoma (Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital). Gynecol Oncol. 2004;92:648–652

PII: S1931-7204(07)00108-0

doi: 10.1016/j.jsurg.2007.03.008

Journal of Surgical Education
Volume 64, Issue 4 , Pages 212-219 , July 2007

Article Tools

* Image Usage & Resolution